Breaking News

Donaldson Acquires Univercells Technologies

Alliance broadens Donaldson’s life sciences reach.

Donaldson, a provider of filtration products and solutions, acquired Univercells Technologies, a global producer of biomanufacturing solutions for cell and gene therapy research, development, and commercial manufacturing. Univercells Technologies’ product offering includes the unique scale-X single-use structured fixed-bed bioreactor for the intensified production of viruses used in cell and gene therapy, viral vaccines, and other therapeutics. In addition, the company’s automated NevoLine Up...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters